Q2 STOCKS TO BUY

2 Drug Stocks Stung by Bearish Analyst Attention

Snap shares are looking for a third straight win

Aug 7, 2017 at 9:26 AM
facebook X logo linkedin


Analysts are weighing in on Snapchat parent Snap Inc (NYSE:SNAP), as well as drug stocks Mylan N.V. (NASDAQ:MYL) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). Here's a quick roundup of today's bearish brokerage notes on shares of SNAP, MYL, and TEVA.

Deutsche Bank Trims Outlook on SNAP 

Snap stock will try for its third straight win today, but a price-target cut to $20 from $23 at Deutsche Bank could hold back the shares. Despite the two-day win streak, SNAP touched a record low last Thursday, before closing Friday at $13.52. This means the social media stock has pulled back some 54% since its record peak of $29.44 from March 3. Most analysts are already bearish on Snap, with 17 of 26 covering brokerage firms dishing out "hold" or "strong sell" recommendations. 

Mylan Stock Could Hit Fresh Lows After Morgan Stanley Note

Morgan Stanley cut its price target on Mylan stock to $36 from $52, dropping the shares 3% in electronic trading. The company just reported disappointing earnings last week, which sent MYL to a four-year low of $32.77, before it closed Friday at $32.92. 

Analysts don't appear to be the only ones growing more bearish on Mylan, either. That is, short interest on the equity grew by 16% during the past two reporting periods alone. Going by average daily volumes, these bears now control more than six days' worth of buying power. In other news, the company announced its TLD combination for HIV and AIDS has received tentative approval from the Food and Drug Administration (FDA). 

Teva Woes Persist with Bearish Analyst Attention

Morgan Stanley also weighed in on shares of Teva Pharmaceuticals, downgrading the stock to "underweight" from "equal weight" and slashing its price target to $16 from $36. Barclays also lowered its price target, dropping it to $23 from $38. This comes after TEVA shares on Friday dropped over 13% to hit a 14-year low of $20.41, before closing at $20.60.

Meanwhile, options traders have also been more bearish than usual. Data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows a 10-day put/call volume ratio of 1.02, which ranks in the 73rd annual percentile. In other words, put buying has been more popular than normal, relative to call buying. Meanwhile, the company just announced that the FDA approved its QVAR RediHaler

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter